Platelet-rich autologous plasma: what is it and for what?

Platelet-rich autologous plasma (PRP) is often used in various branches of medicine. The scope of PRP therapy has expanded from stimulating bone regeneration, healing wounds and ulcers, and musculoskeletal injuries to improving the ability to engrave various types of grafts. Due to the natural properties of platelet-rich plasma, its introduction into the human body is one of the most promising procedures for tissue restoration. After the destruction of platelets, PRP contains α-granules, from which many factors are released after activation, such as transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VGFF) and epidermal growth factor (EGF). The current state of the problem of using APOT has a huge perspective on the development of the methodology, which is due to many aspects that make this procedure simple. PRP can improve the course of many urological diseases, such as erectile dysfunction, Peyronie’s disease, urethral stricture, vesicovaginal fistulas, interstitial cystitis, and stress urinary incontinence. There are many protocols for preparing PRP, each of which has its standardized parameters and stated results. The article presents a review of the literature on the use of platelet-rich plasma in urology, focuses on the definition of PRP, various methods of preparation and activation, as well as the concentration of growth factors.

platelet-rich plasma, urology, erectile dysfunction, vesicovaginal fistulas, Peyronie’s disease, interstitial cystitis, urethral strictures

1. Achkasov E.E., Bezuglov E.N., Ul’Yanov E.N., Ul’Yanov A.A., Kurshev V.V., Repetyuk A.D. Application platelet-rich plasma in clinical practice. Journal Biomed. 2013;1(4):46‒59. (In Russ.).

2. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg. 1986;204(3):322‒330. https://doi.org/10.1097/00000658-198609000-00011

3. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999;14(4):529‒535. PMID: 10453668.

4. Wu YN, Wu CC, Sheu MT, Chen KC, Ho HO, Chiang HS. Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model. J Tissue Eng Regen Med. 2016;10(10):E294‒ E304. https://doi.org/10.1002/term.1806

5. Ding XG, Li SW, Zheng XM, Hu LQ, Hu WL, Luo Y. The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model. Asian J Androl. 2009;11(2):215‒221. https://doi.org/10.1038/aja.2008.37

6. Chalyj M.E., Grigorjan V.A., Epifanova M.V., Krasnov A.O. The effectiveness of intracavernous autologous platelet-rich plasma in the treatment of erectile dysfunction. Urologiia. 2015;(4):76‒79. (In Russ.).

7. Tavukcu HH, Aytaç Ö, Atuğ F, Alev B, Çevik Ö, Bülbül N, Yarat A, Çetinel Ş, Şener G, Kulaksızoğlu H. Protective effect of platelet-rich plasma on urethral injury model of male rats. Neurourol Urodyn. 2018;37(4):1286‒1293. https://doi.org/10.1002/nau.23460

8. Sekerci CA, Tanidir Y, Sener TE, Sener G, Cevik O, Yarat A, Alev-Tuzuner B, Cetinel S, Kervancioglu E, Sahan A, Akbal C. Effects of platelet-rich plasma against experimental ischemia/reperfusion injury in rat testis. J Pediatr Urol. 2017;13(3):317.e1‒317.e9. https://doi.org/10.1016/j.jpurol.2016.12.016

9. Culha MG, Erkan E, Cay T, Yücetaş U. The Effect of PlateletRich Plasma on Peyronie’s Disease in Rat Model. Urol Int. 2019;102(2):218‒223. https://doi.org/10.1159/000492755

10. Dönmez Mİ, İnci K, Zeybek ND, Doğan HS, Ergen A. The Early Histological Effects of Intravesical Instillation of Platelet-Rich Plasma in Cystitis Models. Int Neurourol J. 2016;20(3):188‒196. https://doi.org/10.5213/inj.1632548.274

11. Ozyuvali E, Yildirim ME, Yaman T, Kosem B, Atli O, Cimentepe E. Protective Effect of Intravesical Platelet-Rich Plasma on Cyclophosphamide-Induced Hemorrhagic Cystitis. Clin Invest Med. 20161;39(6):27514. PMID: 27917804.

12. Muzi F, Delicato G, D’Andria D, Baffigo G, Tartaglia E, Tati E, Corvese F, Signore S, Perla A, Montagna G, Tati G.Carboxytherapy and Platelet Rich Plasma: A New Therapy for Trigonitis, Abacterial and Interstitial Cystitis. Journal of Pharmacy and Pharmacology. 2015;(3):405‒410. https://doi.org/10.17265/2328-2150/2015.09.001

13. Jhang JF, Wu SY, Lin TY, Kuo HC. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study. Low Urin Tract Symptoms. 2019;11(2):O42‒O47. https://doi.org/10.1111/ luts.12212

14. Jhang JF, Lin TY, Kuo HC. Intravesical injections of plateletrich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment ‒ A prospective clinical trial. Neurourol Urodyn. 2019;38(2):703‒709. https://doi.org/10.1002/nau.23898

15. Matz EL, Pearlman AM, Terlecki RP. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol. 2018;59(1):61‒65 https://doi.org/10.4111/icu.2018.59.1.61

16. Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Corrêa do Amaral RJ, Granjeiro JM, Borojevic R. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4(3):67. https://doi.org/10.1186/scrt218

17. Perez AG, Lana JF, Rodrigues AA, Luzo AC, Belangero WD, Santana MH. Relevant aspects of centrifugation step in the preparation of platelet-rich plasma. ISRN Hematol. 2014;2014:176060. https://doi.org/10.1155/2014/176060

18. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg. 2000;58(3):297- 300; discussion 300‒301. https://doi.org/10.1016/s0278-2391(00)90058-2

19. Jo CH, Roh YH, Kim JE, Shin S, Yoon KS. Optimizing platelet-rich plasma gel formation by varying time and gravitational forces during centrifugation. J Oral Implantol. 2013;39(5):525‒532. https://doi.org/10.1563/AAID-JOID-10-00155

20. Anitua E, Prado R, Sánchez M, Orive G. Platelet-richplasma: Preparation and formulation. Oper Tech Orthop. 2013;22(1):25–32. https://doi.org/10.1053/j.oto.2012.01.004

21. Callan MB, Shofer FS, Catalfamo JL. Effects of anticoagulant on pH, ionized calcium concentration, and agonist-induced platelet aggregation in canine platelet-rich plasma. Am J Vet Res. 2009;70(4):472‒477. https://doi.org/10.2460/ajvr.70.4.472

22. Guder WG, Narayanan S, Wisser H, Zawta B. Special Aspects of Haematological Analysis: Diagnostic Samples: From the Patient to the Laboratory: The Impact of Preanalytical Variables on the Quality of Laboratory Results. 4th ed. Wiley – Blackwell, Publications; 2009: 36–37.

23. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225‒228. https://doi.org/10.1097/00008505-200110000-00002

24. Kahn RA, Cossette I, Friedman LI. Optimum centrifugation conditions for the preparation of platelet and plasma products. Transfusion. 1976;16(2):162‒165. https://doi.org/10.1046/j.1537-2995.1976.16276155111.x

25. Slichter SJ, Harker LA. Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood. Br J Haematol. 1976;34(3):395‒402. https://doi.org/10.1111/j.1365-2141.1976.tb03586.x

26. Bausset O, Giraudo L, Veran J, Magalon J, Coudreuse JM, Magalon G, Dubois C, Serratrice N, Dignat-George F, Sabatier F. Formulation and storage of platelet-rich plasma homemade product. Biores Open Access. 2012;1(3):115‒123. https://doi.org/10.1089/biores.2012.0225

27. Tamimi FM, Montalvo S, Tresguerres I, Blanco Jerez L. A comparative study of 2 methods for obtaining platelet-rich plasma. J Oral Maxillofac Surg. 2007;65(6):1084‒1093. https://doi.org/10.1016/j.joms.2006.09.012

28. Mazzocca AD, McCarthy MB, Chowaniec DM, Cote MP, Romeo AA, Bradley JP, Arciero RA, Beitzel K. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94(4):308‒316. https://doi.org/10.2106/JBJS.K.00430

29. Anitua E, Aguirre JJ, Algorta J, Ayerdi E, Cabezas AI, Orive G, Andia I. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater. 2008;84(2):415‒421. https://doi.org/10.1002/jbm.b.30886

30. Dugrillon A, Eichler H, Kern S, Klüter H. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg. 2002;31(6):615‒619. https://doi.org/10.1054/ ijom.2002.0322

31. Araki J, Jona M, Eto H, Aoi N, Kato H, Suga H, Doi K, Yatomi Y, Yoshimura K. Optimized preparation method of plateletconcentrated plasma and noncoagulating plateletderived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods. 2012;18(3):176‒185. https://doi.org/10.1089/ten.TEC.2011.0308

32. Sweeny J, Grossman BJ. Methods for collecting, storing, and preparing blood. In: Brecher M, editor. Technical manual. 14th ed. Bethesda, MD: American Association of blood banks (AABB); 2002: 955–958

33. Macey M, Azam U, McCarthy D, Webb L, Chapman ES, Okrongly D, Zelmanovic D, Newland A. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. Clin Chem. 2002;48(6 Pt 1):891‒899. PMID: 12029005.

34. International Cellular Medicine Society. Guidelines for the use of platelet rich plasma (adopted 2011). Available at: http://www.cellmedicinesociety.org/icms-guidelines Accessed April 20, 2020.

35. Kececi Y, Ozsu S, Bilgir O. A cost-effective method for obtaining standard platelet-rich plasma. Wounds. 2014;26(8):232‒238. PMID: 25860639.

36. Tsay RC, Vo J, Burke A, Eisig SB, Lu HH, Landesberg R. Differential growth factor retention by platelet-rich plasma composites. J Oral Maxillofac Surg. 2005;63(4):521‒528. https://doi.org/10.1016/j.joms.2004.09.012

37. Kakudo N, Minakata T, Mitsui T, Kushida S, Notodihardjo FZ, Kusumoto K. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg. 2008;122(5):1352‒1360. https://doi.org/10.1097/PRS.0b013e3181882046

38. Eppley BL, Pietrzak WS, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg. 2006;118(6):147e‒159e. https://doi.org/10.1097/01.prs.0000239606.92676.cf

39. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638-46. https://doi.org/10.1016/s1079-2104(98)90029-4

40. Weibrich G, Kleis WK, Hafner G, Hitzler WE. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg. 2002;30(2):97‒102. https://doi.org/10.1054/jcms.2002.0285

41. Huang Q, Wang YD, Wu T, Jiang S, Hu YL, Pei GX. Preliminary separation of the growth factors in platelet-rich plasma: effects on the proliferation of human marrow-derived mesenchymal stem cells. Chin Med J (Engl). 2009;122(1):83‒87. PMID: 19187622.

42. Pietramaggiori G, Kaipainen A, Czeczuga JM, Wagner CT, Orgill DP. Freeze-dried platelet-rich plasma shows beneficial healing properties in chronic wounds. Wound Repair Regen. 2006;14(5):573‒580. https://doi.org/10.1111/j.1743- 6109.2006.00164.x

43. Marlovits S, Mousavi M, Gäbler C, Erdös J, Vécsei V. A new simplified technique for producing platelet-rich plasma: a short technical note. Eur Spine J. 2004;13 Suppl 1(Suppl 1):S102‒106. https://doi.org/10.1007/s00586-004-0715-3

44. Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on periimplant bone regeneration. Bone. 2004;34(4):665‒671. https://doi.org/10.1016/j.bone.2003.12.010

45. Woodell-May JE, Ridderman DN, Swift MJ, Higgins J. Producing accurate platelet counts for platelet rich plasma: validation of a hematology analyzer and preparation techniques for counting. J Craniofac Surg. 2005;16(5):749‒756; discussion 757‒759. https://doi.org/10.1097/01.scs.0000180007.30115.fa

46. Weiser L, Bhargava M, Attia E, Torzilli PA. Effect of serum and platelet-derived growth factor on chondrocytes grown in collagen gels. Tissue Eng. 1999;5(6):533‒544. https://doi.org/10.1089/ten.1999.5.533

47. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225‒228. https://doi.org/10.1097/00008505-200110000-00002